Human keratinocytes release high levels of inducible heat shock protein 70 that enhances peptide uptake

Experimental Dermatology

Volumn 20, Issue 8, 2011, Pages 637-641

  Wang, Dong ^a   Eiz Vesper, Britta ^a   Zeitvogel, Jana ^a   Dressel, Ralf ^b   Werfel, Thomas ^a   Wittmann, Miriam ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Danger associated molecular patterns; Heat shock protein 70; Human primary keratinocytes; Skin inflammation

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 27; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LYMPHOCYTE; MACROPHAGE; PROTEIN DETERMINATION; PROTEIN TRANSPORT; SKIN INFLAMMATION;

BIOPSY; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; LUPUS ERYTHEMATOSUS, CUTANEOUS; PEPTIDES; SKIN;

EID: 79960331603     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01287.x     Document Type: Article

References (49)

1. Meimaridou E, Gooljar S B, Chapple J P. J Mol Endocrinol 2009: 42: 1-9.
2. Calderwood S K, Mambula S S, Gray P J Jr. Ann N Y Acad Sci 2007: 1113: 28-39.
3. Srivastava P. Nat Rev Immunol 2002: 2: 185-194.
4. Elsner L, Flugge P F, Lozano J et al. J Cell Mol Med 2010: 14: 992-1002.
5. Figueiredo C, Wittmann M, Wang D et al. Blood 2009: 113: 3008-3016.
6. Mambula S S, Calderwood S K. J Immunol 2006: 177: 7849-7857.
7. Vega V L, Rodriguez-Silva M, Frey T et al. J Immunol 2008: 180: 4299-4307.
8. Hunter-Lavin C, Davies E L, Bacelar M M et al. Biochem Biophys Res Commun 2004: 324: 511-517.
9. Lancaster G I, Febbraio M A. J Biol Chem 2005: 280: 23349-23355.
10. Williams J H, Ireland H E. J Leukoc Biol 2008: 83: 489-492.
11. Asea A, Kraeft S K, Kurt-Jones E A et al. Nat Med 2000: 6: 435-442.
12. Nakamura T, Hinagata J, Tanaka T et al. Biochem Biophys Res Commun 2002: 290: 858-864.
13. Becker T, Hartl F U, Wieland F. J Cell Biol 2002: 158: 1277-1285.
14. Basu S, Binder R J, Ramalingam T et al. Immunity 2001: 14: 303-313.
15. Delneste Y, Magistrelli G, Gauchat J et al. Immunity 2002: 17: 353-362.
16. Theriault J R, Mambula S S, Sawamura T et al. FEBS Lett 2005: 579: 1951-1960.
17. Floto R A, MacAry P A, Boname J M et al. Science 2006: 314: 454-458.
18. Whittall T, Wang Y, Younson J et al. Eur J Immunol 2006: 36: 2304-2314.
19. Asea A, Rehli M, Kabingu E et al. J Biol Chem 2002: 277: 15028-15034.
20. Binder R J, Srivastava P K. Nat Immunol 2005: 6: 593-599.
21. MacAry P A, Javid B, Floto R A et al. Immunity 2004: 20: 95-106.
22. Castellino F, Boucher P E, Eichelberg K et al. J Exp Med 2000: 191: 1957-1964.
23. Knudsen S, Schardt A, Buhl T et al. Exp Dermatol 2010: 19: 108-116.
24. Calderwood S K, Gong J, Theriault J R et al. Novartis Found Symp 2008: 291: 115-131; discussion 31-40.
25. Curry J L, Qin J Z, Bonish B et al. Arch Pathol Lab Med 2003: 127: 178-186.
26. Boyman O, Conrad C, Dudli C et al. Br J Dermatol 2005: 152: 1211-1218.
27. Furukawa F, Ikai K, Matsuyoshi N et al. J Invest Dermatol 1993: 101: 191-195.
28. Ghoreishi M, Katayama I, Yokozeki H et al. J Dermatol 1993: 20: 400-405.
29. Pablos J L, Carreira P E, Martin-Villa J M et al. Br J Rheumatol 1995: 34: 721-723.
30. Sanchez-Rodriguez S H, Herrera-van Oostdam D, Avalos-Diaz E et al. Reumatismo 2007: 59: 292-298.
31. Villalobos-Hurtado R, Sanchez-Rogriguez S H, Avalos-Diaz E et al. Reumatismo 2003: 55: 155-158.
32. Fang S, Zeng F, Guo Q. Acta Biochim Biophys Sin (Shanghai) 2008: 40: 989-995.
33. Pockley A G, Muthana M, Calderwood S K. Trends Biochem Sci 2008: 33: 71-79.
34. Currier J R, Kuta E G, Turk E et al. J Immunol Methods 2002: 260: 157-172.
35. Wang D, Drenker M, Eiz-Vesper B et al. Arthritis Rheum 2008: 58: 3205-3215.
36. Wittmann M, Zeitvogel J, Wang D et al. J Allergy Clin Immunol 2009: 124: 81-89.
37. Mambula S S, Stevenson M A, Ogawa K et al. Methods 2007: 43: 168-175.
38. Jarvis M, Marzolini M, Wang X N et al. Transplantation 2003: 76: 849-853.
39. Novota P, Sviland L, Zinocker S et al. Transplantation 2008: 85: 1809-1816.
40. Bayramgurler D, Ozkara S K, Apaydin R et al. J Cutan Pathol 2004: 31: 586-594.
41. Ghoreishi M, Yokozeki H, Hua W M et al. J Dermatol 2000: 27: 370-379.
42. Boehncke W H, Dahlke A, Zollner T M et al. Arch Dermatol Res 1994: 287: 68-71.
43. Asea A. Novartis Found Symp 2008: 291: 173-179; discussion 9-83, 221-4.
44. Radons J, Multhoff G. Exerc Immunol Rev 2005: 11: 17-33.
45. Svensson P A, Asea A, Englund M C et al. Atherosclerosis 2006: 185: 32-38.
46. Luo X, Zuo X, Zhang B et al. Cell Stress Chaperones 2008: 13: 365-373.
47. Lipsker D, Ziylan U, Spehner D et al. Eur J Immunol 2002: 32: 322-332.
48. Delneste Y. Biochem Soc Trans 2004: 32: 633-635.
49. Srivastava P. Annu Rev Immunol 2002: 20: 395-425.